‘New era in brain science’ creates map revealing hundreds of brain cell types

LA JOLLA, Calif. — Researchers at the Salk Institute have successfully crafted a detailed “atlas” of the human brain, revealing hundreds of different cell types. This landmark study could revolutionize our understanding of brain development, aging, and diseases. The findings are so comprehensive they could serve as a roadmap for future neurological research. This could also be a game-changer in neuroscience, paving the way for innovative treatments and therapies.

This wasn’t just a small-scale study; the sheer volume of data collected is impressive. Researchers analyzed over 500,000 brain cells from 46 regions in the brains of three healthy adult male organ donors using methods previously tested on mice. The study reveals that while mouse brains contain roughly 80 million neurons and are largely the same from animal to animal, human brains are extremely diverse and contain about 80 billion neurons.

This is the first time techniques developed for mice have been successfully applied to human brains, providing a detailed map of hundreds of cell types. The research’s success validates the methods and opens up new avenues for more targeted and expansive studies in the future.

“This is really the beginning of a new era in brain science, where we will be able to better understand how brains develop, age, and are affected by disease,” says Professor Joseph Ecker, director of Salk’s Genomic Analysis Laboratory, in a media release.

Prof. Ecker’s enthusiasm highlights the study’s pivotal role in advancing neuroscience. The researcher underscores the potential impact of these findings on multiple facets of brain science, from developmental biology to gerontology and neurology.

The research is part of the National Institute of Health’s Brain Research Through Advancing Innovative Neurotechnologies Initiative (The BRAIN Initiative). This initiative was launched in 2014 and aims to provide a complete cell-level understanding of mammalian brains. The BRAIN Initiative is a multi-institutional effort, and the Salk Institute is one of the key players contributing to this ambitious project. Their work complements studies from other organizations, creating a more complete picture of the brain’s complexities.

An abstract representation of cell diversity in the brain.
An abstract representation of cell diversity in the brain. Individual nuclei are colored in the bright hues of t-SNE plots used in epigenomics analysis to distinguish individual brain cell types. Layers of background color represent the local environmental factors of each brain region that influence cell function. (CREDIT: Michael Nunn)

“Once we scale up our techniques to a large number of brains, we can start to tackle questions that we haven’t been able to in the past,” says Margarita Behrens, a research professor at Salk’s Computational Neurobiology Laboratory.

Behrens emphasizes the methods’ scalability, suggesting that this is just the tip of the iceberg. Her conclusions hint at the breadth of questions that could be answered in future studies, ranging from genetic predispositions to individual differences in brain function.

The implications of this study are monumental. A deeper understanding of the brain’s cell types could lead to more targeted treatments for brain disorders like Alzheimer’s disease, schizophrenia, and depression. It brings us closer to potentially preventing or reversing harmful changes in the brain.

“The potential to find unique cell types in humans that we don’t see in mice is really exciting,” says Wei Tian, co-first author of the new paper and a staff scientist in Ecker’s lab.

This groundbreaking study advances our fundamental understanding of the brain and opens the door to new avenues for treating brain disorders. It emphasizes the importance of continued research to unlock the secrets of our most complex organ. As we delve deeper into this intricate organ, each discovery brings us one step closer to solving some of humanity’s most pressing health challenges.

The study is published in the journal Science.

You might also be interested in:

YouTube video

Follow on Google News

About the Author

Alexander Olumese, PharmD

Alexander Olumese is a DMV-based registered pharmacist and medical writer. He has over 10 years of experience with community and hospital pharmacies, as well as over 3 years within the pharmaceutical industry as a medical writer within medical affairs. He has a background in a variety of therapeutic areas. However, he specializes in cardiovascular disease, oncology, pain medicine, and infectious disease.

The contents of this website do not constitute advice and are provided for informational purposes only. See our full disclaimer

Leave a Reply

Your email address will not be published. Required fields are marked *